EveryLife Foundation for Rare Disease Mission Officer Kennedy Testifies Before Senate Special Committee on Aging
March 07, 2026
March 07, 2026
WASHINGTON, March 7 -- The Senate Special Committee on Aging released the following written testimony by Annie Kennedy, chief mission officer for the EveryLife Foundation for Rare Diseases, from a Feb. 26, 2026, hearing entitled "From Regulator to Roadblock: How FDA Bureaucracy Stifles Innovation." FDA is the Food and Drug Administration.
* * *
Thank you, Chairman Scott, Ranking Member Gillibrand, and distinguished members of the Committee, for convening this . . .
* * *
Thank you, Chairman Scott, Ranking Member Gillibrand, and distinguished members of the Committee, for convening this . . .